Skip to main content
. Author manuscript; available in PMC: 2023 Dec 11.
Published in final edited form as: Hum Mutat. 2023 Mar 29;2023:9537832. doi: 10.1155/2023/9537832

Table 3.

Points per proband that can be applied toward PS2 and/or PS4 application based on proband phenotype and confirmed or assumed de novo status. Modified from “SVI Recommendation for De Novo Criteria (PS2 & PM6)” – Version 1.0

Points per Proband
PS2 PS4 Proband Phenotype (see Table 2)
Phenotypic Consistency Confirmed Assumed
Phenotype highly specific for gene 2 1 1
  1. ≥1 High OR

  2. ≥2 Moderate OR

  3. 1 Moderate AND
    1. ≥1 low OR
    2. High or moderate in 1st or 2nd-degree relative (unless known not to carry variant).
Phenotype consistent with gene but not highly specific 1 0.5 0.5 IV. 1 Moderate
Phenotype consistent with gene but not highly specific and high genetic heterogeneity 0.5 0.25 0 V. ≥1 Low

If PP1 is applied and the proband’s family contributed to the PP1 meiosis count, use IV (1 Moderate) instead of III.B to avoid double counting family history.

Maximum allowable value of 1 may contribute to overall PS2 score to avoid counting multiple probands with only low-specificity phenotypes.